The specific activity of sTK1 was measured in a relatively large group of dogs with CMT and was found to be about half that of sTK1 in healthy dogs and about 2% of that observed in the ALL dog, which is very close to results observed with recombinant canine TK1 [38]. Here, TK1 is linked to acute lymphoblastic leukemia.